Andina Capital Management LLC Takes Position in Tenet Healthcare Corporation $THC

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Andina Capital Management LLC bought a new stake in Tenet Healthcare Corporation (NYSE:THC - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm bought 3,229 shares of the company's stock, valued at approximately $434,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in Tenet Healthcare in the first quarter valued at approximately $26,000. Wayfinding Financial LLC bought a new position in shares of Tenet Healthcare in the 1st quarter valued at $28,000. N.E.W. Advisory Services LLC acquired a new position in shares of Tenet Healthcare during the 1st quarter worth $31,000. Brooklyn Investment Group lifted its position in shares of Tenet Healthcare by 908.7% during the 1st quarter. Brooklyn Investment Group now owns 232 shares of the company's stock worth $31,000 after buying an additional 209 shares during the last quarter. Finally, Colonial Trust Co SC grew its position in Tenet Healthcare by 85.7% in the fourth quarter. Colonial Trust Co SC now owns 247 shares of the company's stock valued at $31,000 after acquiring an additional 114 shares during the last quarter. Institutional investors own 95.44% of the company's stock.

Wall Street Analyst Weigh In

THC has been the topic of a number of research analyst reports. Barclays reduced their price target on shares of Tenet Healthcare from $215.00 to $208.00 and set an "overweight" rating on the stock in a research note on Thursday, July 24th. Wall Street Zen upgraded shares of Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Saturday, July 26th. Raymond James Financial reiterated an "outperform" rating and set a $200.00 price target (up from $185.00) on shares of Tenet Healthcare in a report on Wednesday, July 23rd. UBS Group raised their price objective on Tenet Healthcare from $230.00 to $238.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Finally, The Goldman Sachs Group upped their target price on Tenet Healthcare from $134.00 to $154.00 and gave the stock a "neutral" rating in a report on Monday, May 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $191.88.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 1,222 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $164.96, for a total transaction of $201,581.12. Following the completion of the sale, the director directly owned 22,377 shares in the company, valued at approximately $3,691,309.92. This trade represents a 5.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director James L. Bierman sold 4,613 shares of the business's stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $170.00, for a total value of $784,210.00. Following the completion of the transaction, the director directly owned 35,271 shares in the company, valued at $5,996,070. This represents a 11.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 36,825 shares of company stock valued at $6,141,221. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Trading Down 2.4%

Shares of THC traded down $4.30 during mid-day trading on Thursday, reaching $177.64. 848,409 shares of the company were exchanged, compared to its average volume of 1,221,312. The business has a 50 day simple moving average of $168.36 and a two-hundred day simple moving average of $149.36. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $185.25. The stock has a market capitalization of $15.69 billion, a PE ratio of 11.37, a PEG ratio of 0.78 and a beta of 1.52. The company has a debt-to-equity ratio of 2.39, a quick ratio of 1.63 and a current ratio of 1.71.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, beating analysts' consensus estimates of $2.84 by $1.18. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The business had revenue of $5.27 billion during the quarter, compared to the consensus estimate of $5.16 billion. During the same quarter in the prior year, the firm posted $2.31 EPS. The company's revenue for the quarter was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. On average, analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.